| TorsinA participates in endoplasmic reticulum-associated degradation FC Nery, IA Armata, JE Farley, JA Cho, U Yaqub, P Chen, CC Da Hora, ... Nature communications 2 (1), 393, 2011 | 132 | 2011 |
| Patient-derived glioma models: from patients to dish to animals CC da Hora, MW Schweiger, T Wurdinger, BA Tannous Cells 8 (10), 1177, 2019 | 121 | 2019 |
| Stearoyl CoA desaturase is essential for regulation of endoplasmic reticulum homeostasis and tumor growth in glioblastoma cancer stem cells K Pinkham, DJ Park, A Hashemiaghdam, AB Kirov, I Adam, K Rosiak, ... Stem cell reports 12 (4), 712-727, 2019 | 78 | 2019 |
| Dissecting inherent intratumor heterogeneity in patient-derived glioblastoma culture models J Teng, C Carla da Hora, RS Kantar, I Nakano, H Wakimoto, TT Batchelor, ... Neuro-oncology 19 (6), 820-832, 2017 | 63 | 2017 |
| Post–COVID-19 acute disseminated encephalomyelitis in a 17-month-old LA McLendon, CK Rao, CC Da Hora, F Islamovic, FN Galan Pediatrics 147 (6), 2021 | 38 | 2021 |
| Biochemical and cellular analysis of human variants of the DYT 1 dystonia protein, TorsinA/TOR1A J Hettich, SD Ryan, ON de Souza, LF Saraiva Macedo Timmers, S Tsai, ... Human mutation 35 (9), 1101-1113, 2014 | 30 | 2014 |
| Sustained NF-κB-STAT3 signaling promotes resistance to Smac mimetics in Glioma stem-like cells but creates a vulnerability to EZH2 inhibition CC da Hora, K Pinkham, L Carvalho, M Zinter, E Tabet, I Nakano, ... Cell death discovery 5 (1), 72, 2019 | 29 | 2019 |
| AAV9 transduction mediated by systemic delivery of vector via retro-orbital injection in newborn, neonatal and juvenile mice S Prabhakar, S Lule, CC Da Hora, XO Breakefield, PS Cheah Experimental Animals 70 (4), 450-458, 2021 | 20 | 2021 |
| Obtusaquinone: a cysteine-modifying compound that targets Keap1 for degradation CE Badr, CC Da Hora, AB Kirov, E Tabet, R Amante, S Maksoud, ... ACS chemical biology 15 (6), 1445-1454, 2020 | 19 | 2020 |
| New methods for investigation of neuronal migration in embryonic brain explants FC Nery, CC da Hora, U Yaqub, X Zhang, DM McCarthy, PG Bhide, ... Journal of neuroscience methods 239, 80-84, 2015 | 19 | 2015 |
| A multiplexed bioluminescent reporter for sensitive and non-invasive tracking of DNA double strand break repair dynamics in vitro and in vivo JCY Chien, E Tabet, K Pinkham, CC da Hora, JCY Chang, S Lin, CE Badr, ... Nucleic acids research 48 (17), e100-e100, 2020 | 17 | 2020 |
| Microfluidic platform to evaluate migration of cells from patients with DYT1 dystonia FC Nery, CC da Hora, NA Atai, EY Kim, J Hettich, TR Mempel, ... Journal of neuroscience methods 232, 181-188, 2014 | 11 | 2014 |
| TorsinA participates in endoplasmic reticulum-associated degradation. Nat Commun 2: 393 FC Nery, IA Armata, JE Farley, JA Cho, U Yaqub, P Chen, CC da Hora, ... | 7 | 2011 |
| Patient‑derived glioma models: from patients to dish to animals. Cells 8: 1177 CC da Hora, MW Schweiger, T Wurdinger, BA Tannous | 6 | 2019 |
| Patient-derived glioma models: from patients to dish to animals. Cells 2019; 8 (10): 1177 CC da Hora, MW Schweiger, T Wurdinger, BA Tannous | 5 | |
| Author Correction: Sustained NF-κB-STAT3 signaling promotes resistance to Smac mimetics in Glioma stem-like cells but creates a vulnerability to EZH2 inhibition CC da Hora, K Pinkham, L Carvalho, M Zinter, E Tabet, I Nakano, ... Cell Death Discovery 5, 2019 | 1 | 2019 |
| Diastereomers of Coibamide A Show Altered Sec61 Client Selectivity and Ligand-Dependent Activity against Patient-Derived Glioma Stem-like Cells DR Mattos, W Neves, T Kitamura, R Pradhan, X Wan, CC da Hora, ... ACS Pharmacology & Translational Science, 2024 | | 2024 |
| Overcoming therapy resistance and treatment failure in glioblastoma CC da Hora | | 2023 |
| Multiplexed Bioluminescent Reporter Enables Non-Invasive Tracking of DNA Double Strand Break Repair Dynamics In Vitro and In Vivo JCY Chien, E Tabet, CC da Hora, JCY Chang, K Pinkham, S Lin, CE Badr, ... MOLECULAR THERAPY 28 (4), 284-284, 2020 | | 2020 |
| Abstract B112: Obtusaquinone is a cysteine-modifying compound that targets Keap1 for degradation CC Hora, E Tabet, CE Badr, B Tannous Molecular Cancer Therapeutics 18 (12_Supplement), B112-B112, 2019 | | 2019 |